Single dose moxidectin versus ivermectin for Onchocerca volvulus infection in Ghana, Liberia, and the Democratic Republic of the Congo: a randomised, controlled, double-blind phase 3 trial

susan's picture

The morbidity and socioeconomic effects of onchocerciasis, a parasitic disease that is primarily endemic in sub-Saharan Africa, have motivated large morbidity and transmission control programmes. Annual communitydirected ivermectin treatment has substantially reduced prevalence.

Name of the Journal: 
Main Topic: 
Mark Content Private(Internal): 
External URL: 
https://www.thelancet.com/pdfs/journals/lancet/PIIS0140-6736(17)32844-1.pdf
Email Alert: 
1207-1216
392
Publication Date: 
06/10/2018